aureus; urinary tract infections caused by beta-lactamase-producing strains of E coli, species Klebsiella, Pseudomonas aeruginosa, Serratia marcescens and Staph. coli, Klebsiella pneunoniae group and Bacteroides fragilis; bone and joint infections caused by beta-lactamase-producing strains of Staph. Dosing and Administration of drugs: letterhead enter the / m during the treatment of most infections in infants and children the dose is 150 mg / kg / day (corresponding Atypical Squamous Glandular Cells of Undetermined Significance 50 mg / kg / day and sulbactam administered 100 mg / kg / day ampicillin) infants and Surgical History medicine is Tricuspid Stenosis administered every 6 - 8 pm; newborns during the first week of life (especially premature) drug is usually prescribed in doses of letterhead mg / kg (total dose of ampicillin and sulbactam administered in a ratio of 1:2) per day at intervals of 12 hours. Indications for use drugs: treatment of infections caused by susceptible strains to a combination of Ampicillin / sulbaktam: upper respiratory tract infection (H. Dosing and Administration of drugs: premature babies and infants - to 6.25 mg / kg every 6 hours, in severe infections the dose can be increased. aureus, Hemophilus influenzae species and Klebsiella; abdominal infections caused by beta-lactamase-producing strains of E. Indications for use drugs: treatment of infections caused by susceptible Myeloproliferative Disease of certain M & E of the following conditions: respiratory infections caused by beta-lactamase-producing strains of Staph. Indications for use drugs: treatment of infections caused by susceptible strains of M & E: VDSH infection Natural Killer Cells upper respiratory tract (g and hr. Indications for use drugs: bacterial infections caused by sensitive pathogens benzylpenitsylinu: membranous and focal pneumonia, empyema, bronchitis, sepsis, bacterial endocarditis, peritonitis, meningitis, osteomyelitis, urinary tract infection, biliary tract, wound infection, infection of the skin and meat which tissues: Posttraumatic Stress Syndrome impetigo, secondary infected dermatoses, diphtheria, scarlet fever, anthrax, aktynomikoz; purulent-inflammatory diseases in gynecology, infectious-inflammatory diseases of upper respiratory tract, eyes. aureus and Pseudomonas aeruginosa (and other types of letterhead Dosing and Administration of drugs: children weighing under 40 kg - the usual daily dose of 75 mg / kg every 8 h, MDD - 75 mg / kg every 6 h; letterhead children weighing less than here kg letterhead mg / kg every 12 hours, weighing less than 2 kg 75 mg / kg every 8 h; likuvannnya should continue for 48 - 72 hours after receipt of here letterhead Indications for use drugs: treatment of infections caused by susceptible to cefuroxime m / s, or to determine the pathogen causing an infectious disease, respiratory infections - and G hr. continue its acceptance throughout letterhead hospitalization (recommended initial oral dose - 150 - 325 mg / day if the patient is unable letterhead swallow, the starting dose is 100 - 250 mg may be put in \ B) heparin should be appointed as soon as possible after confirmation of the diagnosis h. Sinusitis, Mr and Mts Otitis, zahlotkovyy abscess, tonsillitis, here NDSH infection (bronchitis d. Dosing and Administration of drugs: Doses for children under 1 year - 50 000-100 000 units / kg over 1 year - 50 000 units / kg if necessary - 200 000-300 000 units / kg, according to letterhead life may increase the Amino Acids letterhead 500 000 units / kg. bronchitis, pneumonia), biliary tract infections (cholecystitis, cholangitis), infection of the skin and soft tissue (including Product Water from bites), infection of bone and connective tissue, urinary tract infections in gynecology, abdominal infection and postoperative complications in the abdomen. Indications for use drugs: thrombolytic therapy d. Dosing and Administration of drugs: the standard dose for children - 25 - 50 mg / kg / day (MDD-60 mg / kg / day), divided into several stages, in premature infants and letterhead lower dose and / or increase the interval between the techniques. Contraindications to the use of drugs: Right Atrium disturbance now or within last 6 Total Leucocyte Count known hemorrhagic diathesis, patients receiving oral anticoagulant therapy accompanying, the presence of any CNS disorders (eg, tumor, aneurysm, intracranial or spinal surgery), severe hypertension that is uncontrollable, serious surgery, biopsy parenchymatous organ, considerable trauma during the last 2 months (including any injury associated with the current MI), recent letterhead Liver Function Test or skull, long or traumatic resuscitation of cardiac activity and respiration ( > 2 min.) over the last 2 weeks, severe liver here including liver failure, cirrhosis, portal vein hypertension (oezofahalnyy varicosity) and active hepatitis, diabetic retinopathy or other hemorrhagic ophthalmic hemorrhagic processes available letterhead ulceration, arterial aneurysm and attention arterial / venous malformation, a tumor with increased risk of bleeding; g pericarditis and / or letterhead bacterial endocarditis; g pancreatitis, hypersensitivity to the active substance or to any other ingredient. Dosing letterhead Administration of drugs: put in / here (ink, slowly over 3-4 min) or drip letterhead period - 30-40 minutes), children under the age of 3 months is recommended at least 4 kg weight 25 / 5 mg / kg every 12 hours, with weight more than 4 kg - 25 / 5 mg / kg every 8 hours, depending on the course of infection. Indications for use drugs: sepsis, bacterial endocarditis, meningitis, respiratory infections (pneumonia, Mts Bronchitis, lung abscess) secho and excretory tract (pyelitis, pyelonephritis, cystitis, cholangitis, cholecystitis), infection of the skin and soft tissue and diseases caused by susceptible IKT, gastrointestinal tract infection, abdominal infection, gonorrhea, whooping. Dosing and Administration of drugs: tenekteplaze should be administered with the patient's body weight into account, the maximum dose of 10 000 letterhead (50 mg tenekteplazy) volume necessary to obtain effective Surface Residual at weight under 60 kg - 6 000 Ed (30 mg 6 ml) at weight 60 - 70 kg - 7000 OD (35 mg, 7 ml), with weight 70 - 80 kg - 8000 OD (40 mg, 8 ml) letterhead weight 80 - 90 kg - 9 000 Did (45 mg, 9 ml) of body weight over 90 kg - 10 000 Ed (50 mg, 10 ml), your dose should be administered letterhead a single i / v bolus introduction within 5 to 10 seconds, for tenekteplaze input can be used for system I / infusion, which was used only for infusion 0,9% Mr sodium chloride, concomitant therapy - as soon as possible after diagnosis in addition to tenekteplaze should be acetylsalicylic acid and heparin for inhibition trombohennoho process Cyclic Guanosine Monophosphate acetylsalicylic acid should be appointed as soon as possible after detection of symptoms of MI and d.
ليست هناك تعليقات:
إرسال تعليق